El Salvador is a bright spot. It can become even brighter U.S. Senator Marco Rubio (R-FL) February 23, 2024 Informe Orwell I made my first official visit to El Salvador in March 2023. What I saw was remarkable: under President Nayib Bukele, one of the world’s most...
U.S. Senator Marco Rubio’s (R-FL) office will host in-person Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of Senator Rubio’s...
El Salvador es un punto de optimismo en nuestra región 23 de febrero del 2024 Informe Orwell En marzo del 2023 hice mi primera visita oficial a El Salvador. Es notable resaltar que bajo el gobierno del presidente Nayib Bukele, uno de los países más peligrosos del...
El senador estadounidense Marco Rubio (R-FL) viajó a Asunción, Paraguay en una visita oficial. Durante su viaje, Rubio se reunió con el embajador de Taiwán en Paraguay, José Han, y reafirmó su apoyo inquebrantable a Taiwán. Paraguay es actualmente el último país en...
RUBIO MEETS WITH TAIWANESE AMBASSADOR TO PARAGUAY, JOSÉ HAN U.S. Senator Marco Rubio (R-FL) traveled to Asunción, Paraguay on an official visit. During his trip, Rubio met with Taiwanese Ambassador to Paraguay José Han and reaffirmed his unwavering support of...
El senador estadounidense Marco Rubio (R-FL) viajó a Asunción, Paraguay en una visita oficial. Durante su viaje, Rubio se reunió con el presidente Santiago Peña para hablar sobre los desafíos regionales que enfrentan tanto EE.UU. como Paraguay, la importancia de...
Rubio, Lee, Colleagues Urge HHS to Evaluate Expanding Ethical Sources of Fetal Tissue
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Mike Lee (R-UT) sent a letter, along with more than a dozen of their colleagues, to Secretary of Health and Human Services (HHS) Xavier Becerra requesting that the agency evaluate its ability to expand the existing organ donation network to include preterm and stillborn infant donors, so as to provide an ethical alternative to aborted fetal tissue. The letter also makes it clear that under no circumstance should scientific research and experimentation use cells or tissues derived from abortion.
Senator Rubio is a champion for pro-life protections, and has sent multiple letters opposing the unethical practice of using aborted fetal tissue, most recently in February 2021.
“Respecting the dignity of human life from conception to natural death is critically important and this action would be a significant step toward protecting human life at all stages,” the senators wrote. “If a consistent, high-quality, and ethically uncontroversial source of human fetal tissue exists, medical research would undoubtedly expand, advancing our nation’s understanding of human development and leading to potentially life-saving discoveries.”
For a full list of signers and supporting groups, click here.
The full text of the letter is below.
Dear Secretary Becerra,
We write to express our support for the ethical discovery of treatments and cures that save American lives. Specifically, we request that you evaluate the agency’s ability to expand our nation’s existing organ-donation network to include spontaneously miscarried and stillborn infant donors. We believe doing so could provide a solution to the need for an ethical alternative to aborted fetal tissue and support HHS’s effort to ethically advance the field of medicine.
Respecting the dignity of human life from conception to natural death is critically important and this action would be a significant step toward protecting human life at all stages. If a consistent, high-quality, and ethically uncontroversial source of human fetal tissue exists, medical research would undoubtedly expand, advancing our nation’s understanding of human development and leading to potentially life-saving discoveries. Such a consistent, uncontroversial source of organs and tissues would also meet the requirements as set out in NIH Guide Notice NOT-OD-19-128 and preclude the necessity of Ethics Advisory Board review (per 42 U.S.C. 289a-1, as amended), easing the minds of researchers and advancing superior scientific methods.
Notably, organ donation after the death of a child has been found to bring comfort to grieving parents. But despite this, there is currently only a limited ability to use donated material from preterm and stillborn infants for conventional organ transplant. Expanding the opportunities to make a potentially life-saving donation for basic and clinical research following the tragic loss of an infant due to natural causes would be of great benefit to many grieving parents.
We look forward to a response outlining the ways in which HHS could encourage an expansion of the organ donation network to include an ethical source of human fetal tissue.